A combination of two monoclonal antibodies was effective in 61% of people with the most common form of colorectal cancer, results from a new phase 1 trial indicate.
Advanced colorectal cancer: New immunotherapy combo may be effective
1 year ago
44
Related
Making cancer vaccines more personal
1 week ago
14
Trending
Popular
Reduce your risk of cancer: get involved and have fun
1 year ago
227
Copyright © 2019 - 2025 | Whatiscancer.net | All Rights Reserved.







English (US) ·